Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment.

Tetrault JM, Kozal MJ, Chiarella J, Sullivan LE, Dinh AT, Fiellin DA.

J Addict Med. 2013 Mar-Apr;7(2):102-7. doi: 10.1097/ADM.0b013e31827f9bdf.

2.

A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.

Fiellin DA, Barry DT, Sullivan LE, Cutter CJ, Moore BA, O'Connor PG, Schottenfeld RS.

Am J Med. 2013 Jan;126(1):74.e11-7. doi: 10.1016/j.amjmed.2012.07.005.

3.

Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot study.

Moore BA, Barry DT, Sullivan LE, O╩╝connor PG, Cutter CJ, Schottenfeld RS, Fiellin DA.

J Addict Med. 2012 Sep;6(3):205-11. doi: 10.1097/ADM.0b013e3182596492.

4.

Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians.

Edelman EJ, Dinh AT, Moore BA, Schottenfeld RS, Fiellin DA, Sullivan LE.

J Addict Med. 2012 Jun;6(2):159-65. doi: 10.1097/ADM.0b013e31824339fc.

5.

Factors affecting clinician educator encouragement of routine HIV testing among trainees.

Berkenblit GV, Sosman JM, Bass M, Gebrekristos HT, Cofrancesco J Jr, Sullivan LE, Cook RL, Edison M, Bashook PG, Korthuis PT.

J Gen Intern Med. 2012 Jul;27(7):839-44. doi: 10.1007/s11606-012-1985-9.

6.

Knowledge and perceptions of HIV-infected patients regarding HIV transmission and treatment in Ho Chi Minh City, Vietnam.

Hoang D, Dinh AT, Groce N, Sullivan LE.

Asia Pac J Public Health. 2015 Mar;27(2):NP746-57. doi: 10.1177/1010539511427955. Epub 2011 Dec 23.

PMID:
22199151
7.

Oral substitution treatment of injecting opioid users for prevention of HIV infection.

Gowing L, Farrell MF, Bornemann R, Sullivan LE, Ali R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD004145. doi: 10.1002/14651858.CD004145.pub4. Review.

PMID:
21833948
8.

Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.

Tetrault JM, Tate JP, McGinnis KA, Goulet JL, Sullivan LE, Bryant K, Justice AC, Fiellin DA; Veterans Aging Cohort Study Team.

Alcohol Clin Exp Res. 2012 Feb;36(2):318-24. doi: 10.1111/j.1530-0277.2011.01601.x. Epub 2011 Jul 28.

9.

Provider and practice characteristics associated with use of rapid HIV Testing by general internists.

Bass MG, Korthuis PT, Cofrancesco J Jr, Berkenblit GV, Sullivan LE, Asch SM, Bashook PG, Edison M, Sosman JM, Cook RL.

J Gen Intern Med. 2011 Nov;26(11):1258-64. doi: 10.1007/s11606-011-1764-z. Epub 2011 Jun 28.

10.

General internists' beliefs, behaviors, and perceived barriers to routine HIV screening in primary care.

Korthuis PT, Berkenblit GV, Sullivan LE, Cofrancesco J Jr, Cook RL, Bass M, Bashook PG, Edison M, Asch SM, Sosman JM.

AIDS Educ Prev. 2011 Jun;23(3 Suppl):70-83. doi: 10.1521/aeap.2011.23.3_supp.70.

11.

A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home.

Sullivan LE, Tetrault JM, Braithwaite RS, Turner BJ, Fiellin DA.

Am J Addict. 2011 Jul-Aug;20(4):343-56. doi: 10.1111/j.1521-0391.2011.00143.x. Epub 2011 May 31.

PMID:
21679266
12.

Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications.

Wang EA, McGinnis KA, Fiellin DA, Goulet JL, Bryant K, Gibert CL, Leaf DA, Mattocks K, Sullivan LE, Vogenthaler N, Justice AC; VACS Project Team.

J Gen Intern Med. 2011 Sep;26(9):1012-8. doi: 10.1007/s11606-011-1723-8. Epub 2011 May 15.

13.

The case for routine HIV screening and impact of managed care.

Sullivan LE, Fiellin DA.

Am J Manag Care. 2010 Dec;16(13 Suppl):S345-51.

14.

Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients.

Vergara-Rodriguez P, Tozzi MJ, Botsko M, Nandi V, Altice F, Egan JE, O'Connor PG, Sullivan LE, Fiellin DA; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S62-7. doi: 10.1097/QAI.0b013e31820a820f.

PMID:
21317596
15.

The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.

Sullivan LE, Botsko M, Cunningham CO, O'Connor PG, Hersh D, Mitty J, Lum PJ, Schottenfeld RS, Fiellin DA; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S54-61. doi: 10.1097/QAI.0b013e3182097576.

16.

Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.

Fiellin DA, Weiss L, Botsko M, Egan JE, Altice FL, Bazerman LB, Chaudhry A, Cunningham CO, Gourevitch MN, Lum PJ, Sullivan LE, Schottenfeld RS, O'Connor PG; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S33-8. doi: 10.1097/QAI.0b013e3182097537.

17.

HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.

Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R; BHIVES Collaborative.

J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S22-32. doi: 10.1097/QAI.0b013e318209751e.

18.

Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection.

Sullivan LE, Goulet JL, Justice AC, Fiellin DA.

Drug Alcohol Depend. 2011 Sep 1;117(2-3):158-63. doi: 10.1016/j.drugalcdep.2011.01.014. Epub 2011 Feb 22.

19.

Update in HIV medicine for the generalist.

Chaudhry AA, Berkenblit G, Gifford AL, Cofrancesco J Jr, Sosman J, Sullivan LE.

J Gen Intern Med. 2011 May;26(5):538-42. doi: 10.1007/s11606-010-1580-x. Epub 2010 Dec 8. Review. No abstract available.

20.

Substance use in patients with sexually transmitted infections: results from a national U.S. survey.

Tetrault JM, Fiellin DA, Niccolai LM, Sullivan LE.

Am J Addict. 2010 Nov-Dec;19(6):504-9. doi: 10.1111/j.1521-0391.2010.00087.x. Epub 2010 Sep 21.

PMID:
20958845

Supplemental Content

Loading ...
Support Center